Lexicon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical Update
Go back to Lexicon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical Update| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.89 | 52 Week High | $19.62 | |||
| Open | $1.89 | 52 Week Low | $7.65 | |||
| Day High | $1.89 | P/E | N/A | |||
| Day Low | $1.89 | EPS | $-0.22 | |||
| Volume | 5,471 | |||||
